SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-045026
Filing Date
2021-08-18
Accepted
2021-08-18 16:05:41
Documents
13
Period of Report
2021-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K PATHEON MSA grtx-8k_20210813.htm   iXBRL 8-K 44230
2 EX-10.0 PATHEON MSA grtx-ex100_16.htm EX-10.0 610887
  Complete submission text file 0001564590-21-045026.txt   867821

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grtx-20210813.xsd EX-101.SCH 5685
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20210813_lab.xml EX-101.LAB 19314
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20210813_pre.xml EX-101.PRE 11483
6 EXTRACTED XBRL INSTANCE DOCUMENT grtx-8k_20210813_htm.xml XML 3547
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 211186724
SIC: 2834 Pharmaceutical Preparations